About Ryan

Ryan is a leading biotech executive with over 20 years of experience in driving early-stage drug development to commercial success. He is the President and Chief Operating Officer of Bicara Therapeutics, a private, clinical-stage oncology company developing bifunctional antibodies that combine the precision of well-validated, tumor-targeting antibodies with the power of immunomodulators for synergistic, durable impact at the site of the tumor.

Prior to Bicara, Ryan was a founding executive of Rheos Medicines, an immuno-metabolism company launched from Third Rock Ventures. Previous to that, Ryan was Vice President of Marketing, Operations and Analytics at Takeda Oncology where he was responsible for the company’s commercial oncology portfolio in the U.S. that included four compounds across a range of both Hematological and solid tumors.

Ryan holds a PharmD from Purdue University and is a current member of the Dean’s Advisory Council.